Back to Authors

Osborne, David

Mayo Clinic

Mayo Clinic

Citations 10

Evaluation and Treatment of the Female Urethral Syndrome
Carson, C C, Segura, Joseph W., Osborne, David

Journal of Urology | June 30, 2017 | Volume: 124 | Issue: 5 | Pages: 609-610

10.1016/s0022-5347(17)55578-0 Get It

A Distinctive Interaction Between Chronic Anxiety and Problem Solving in Asymptomatic APOE e4 Homozygotes
Caselli, Richard J. , Reiman, Eric M. , Hentz, Joseph G. , Osborne, David, Alexander, Gene E.

The Journal of Neuropsychiatry and Clinical Neurosciences | December 17, 2014 | Volume: 16 | Issue: 3 | Pages: 320-329

10.1176/jnp.16.3.320 Get It

Counseling Readiness and Changes in Self-Evaluation during Intensive Group Psychotherapy
Osborne, David, Swenson, Wendell M.

Psychological Reports | September 1, 2011 | Volume: 31 | Issue: 2 | Pages: 646-646

10.2466/pr0.1972.31.2.646 Get It

Counseling Readiness and Changes in Perception of Spouse during Intensive Group Therapy
Osborne, David, Swenson, Wendell M., Hardman, John B.

Psychological Reports | September 1, 2011 | Volume: 31 | Issue: 1 | Pages: 208-210

10.2466/pr0.1972.31.1.208 Get It

This study attempted to relate scores on the counseling readiness scale of the Adjective Checklist to changes in perception of spouse during intensive group psychotherapy. The counseling readiness score was found to be unrelated to changes in the number of favorable adjectives used by S to describe the spouse or used by the spouse to describe S. A significant relationship was found between the counseling readiness score and changes in the number of unfavorable adjectives used to describe the spouse and used by the spouse to describe S. Possible reasons for this finding are discussed.
Comparison of the WAIS and WAIS-R at Different Ages in a Clinical Population
Rogers, Dan L., Osborne, David

Psychological Reports | September 1, 2011 | Volume: 54 | Issue: 3 | Pages: 951-956

10.2466/pr0.1984.54.3.951 Get It

Performances on the Wechsler Adult Intelligence Scale (WAIS) and the WAIS-Revised (WAIS-R) were compared between groups at different ages. We studied 176 subjects (primarily outpatients) who were referred for assessment of cognitive function. Although all age groups tended to obtain lower scores on the WAIS-R, older subjects were penalized more on Performance and Full Scale IQs when the revised form was used. However, interactions suggest that differences in the scores on the WAIS and WAIS-R in a clinical population may reflect an interaction among age, presenting complaint, and other factors.
Common Kibra Alleles Are Associated with Human Memory Performance
Papassotiropoulos, Andreas , Stephan, Dietrich , Huentelman, Matthew J. , Craig, David W. , Pearson, John V. , Huynh, Kim-Dung, Brunner, Fabienne, Corneveaux, Jason J., Osborne, David, Wollmer, M. Axel, Aerni, Amanda , Coluccia, Daniel , Hänggi, Jürgen , Mondadori, Christian R.A., Buchmann, Andreas , Reiman, Eric M. , Caselli, Richard J. , Quervain, Dominique J.‐F. de , Hoerndli, Frédéric J. , Henke, Katharina

Science | October 19, 2006 | Volume: 314 | Issue: 5798 | Pages: 475-478

10.1126/science.1129837 Get It

Human memory is a polygenic trait. We performed a genome-wide screen to identify memory-related gene variants. A genomic locus encoding the brain protein KIBRA was significantly associated with memory performance in three independent, cognitively normal cohorts from Switzerland and the United States. Gene expression studies showed that KIBRA was expressed in memory-related brain structures. Functional magnetic resonance imaging detected KIBRA allele–dependent differences in hippocampal activations during memory retrieval. Evidence from these experiments suggests a role for KIBRA in human memory.
P2–194: Presymptomatic longitudinal decline in frontally mediated cognitive skills and memory in cognitively normal late middle aged APOE e4 carriers
Caselli, Richard J. , Hentz, Joseph G. , Osborne, David, Hoffman‐Snyder, Charlene , Alexander, Gene E. , Reiman, Eric M.

Alzheimer's & Dementia | August 17, 2006 | Volume: 2 | Issue: 3S_Part_10 | Pages: No page available

10.1016/j.jalz.2006.05.1032 Get It

[P‐121]: Resting FDG‐PET in neurologically normal individuals reporting dream enactment behavior: Preclinical dementia with lewy bodies?
Caselli, Richard J. , Reiman, Eric M. , Alexander, Gene E. , Osborne, David, Parish, James M., Krahn, Lois E., Chen, Kewei , Boeve, Bradley F.

Alzheimer's & Dementia | August 25, 2005 | Volume: 1 | Issue: 1S_Part_2 | Pages: No page available

10.1016/j.jalz.2005.06.194 Get It

Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism
Reiman, Eric M. , Chen, Kewei , Alexander, Gene E. , Caselli, Richard J. , Bandy, Daniel, Osborne, David, Saunders, Ann M. , Hardy, John , Hardy, John

Proceedings of the National Academy of Sciences | June 2, 2005 | Volume: 102 | Issue: 23 | Pages: 8299-8302

10.1073/pnas.0500579102 Get It

Patients with Alzheimer's disease (AD) have abnormally low positron emission tomography (PET) measurements of the cerebral metabolic rate for glucose (CMRgl) in regions of the precuneus and the posterior cingulate, parietotemporal, and frontal cortex. Apolipoprotein E (APOE) ε4 gene dose (i.e., the number of ε4 alleles in a person's APOE genotype) is associated with a higher risk of AD and a younger age at dementia onset. We previously found that cognitively normal late-middle-aged APOE ε4 carriers have abnormally low CMRgl in the same brain regions as patients with probable Alzheimer's dementia. In a PET study of 160 cognitively normal subjects 47–68 years of age, including 36 ε4 homozygotes, 46 heterozygotes, and 78 ε4 noncarriers who were individually matched for their gender, age, and educational level, we now find that ε4 gene dose is correlated with lower CMRgl in each of these brain regions. This study raises the possibility of using PET as a quantitative presymptomatic endophenotype to help evaluate the individual and aggregate effects of putative genetic and nongenetic modifiers of AD risk.
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, Eric M. , Chen, Kewei , Alexander, Gene E. , Caselli, Richard J. , Bandy, Daniel, Osborne, David, Saunders, Ann M. , Hardy, John , Hardy, John

Proceedings of the National Academy of Sciences | January 6, 2004 | Volume: 101 | Issue: 1 | Pages: 284-289

10.1073/pnas.2635903100 Get It

Fluorodeoxyglucose positron emission tomography (PET) studies have found that patients with Alzheimer's dementia (AD) have abnormally low rates of cerebral glucose metabolism in posterior cingulate, parietal, temporal, and prefrontal cortex. We previously found that cognitively normal, late-middle-aged carriers of the apolipoprotein E ε4 allele, a common susceptibility gene for late-onset Alzheimer's dementia, have abnormally low rates of glucose metabolism in the same brain regions as patients with probable AD. We now consider whether ε4 carriers have these regional brain abnormalities as relatively young adults. Apolipoprotein E genotypes were established in normal volunteers 20–39 years of age. Clinical ratings, neuropsychological tests, magnetic resonance imaging, and PET were performed in 12 ε4 heterozygotes, all with the ε3/ε4 genotype, and 15 noncarriers of the ε4 allele, 12 of whom were individually matched for sex, age, and educational level. An automated algorithm was used to generate an aggregate surface-projection map that compared regional PET measurements in the two groups. The young adult ε4 carriers and noncarriers did not differ significantly in their sex, age, educational level, clinical ratings, or neuropsychological test scores. Like previously studied patients with probable AD and late-middle-aged ε4 carriers, the young ε4 carriers had abnormally low rates of glucose metabolism bilaterally in the posterior cingulate, parietal, temporal, and prefrontal cortex. Carriers of a common Alzheimer's susceptibility gene have functional brain abnormalities in young adulthood, several decades before the possible onset of dementia.